UN’ OTTIMA REVIEW DALLA GASTROENTEROLOGIA DELLA CATTOLICA SULL’ASSE GUT-BRAIN E MICROBIOTA: IBS vs IBD

The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease. Angela Ancona et al. Introduction Gut microbiota (GM) has a critical role on host health accounting for bacteria, virus, archea, fungi, yeasts, parasite and phages [1]. Over the last twenty years, the research on gut microbiota has focused on bacterial components [2]. The majority…

CONFRONTO TRA ANTIBIOTICI PER LA DIVERTICOLITE: UNO STUDIO DI COORTE SUGLI ANNALS – EFFICACY vs HARM

Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis, Two Nationwide Cohort Studies Charles E. Gaber et al. ABSTRACT Background: Outpatient diverticulitis is commonly treated with either a combination of metronidazole and a fluoroquinolone (metronidazole-with-fluoroquinolone) or amoxicillin– clavulanate alone. The U.S. Food and Drug Administration advised that fluoroquinolones be reserved for conditions with no alternative…

LINEE GUIDA AGA SUI PROBIOTICI: UNA PROPOSTA DISCUTIBILE

CLINICAL PRACTICE GUIDELINES AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders Grace L. Su, et al. INTRODUCTION This document presents the official recommendations of the American Gastroenterological Association (AGA) on the role of probiotics in the management of gastrointestinal disorders. The guideline was developed by the AGA Institute’s…

IBS: QUALE DIETA FUNZIONA ? UNA OTTIMA REVIEW

Dietary Interventions and Irritable Bowel Syndrome – What Really Works? Teodora Surdea-Blaga; Anamaria Cozma-Petrut; Dan Lucian Abstract Purpose of Review: The review examines the latest research on the use of dietary interventions in the management of irritable bowel syndrome (IBS) in order to understand what is the evidence supporting the efficacy of a dietary approach in…

RIFAXIMINA PREVIENE ANCHE LA ENCEFALOPATIA POST-TIPS ?

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. A Randomized Controlled Trial Christophe Bureau, MD, PhD et al Background: The efficacy of rifaximin in the secondary prevention of overt hepatic encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode in patients after transjugular…